查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1192975

營養補充品成分市場:各類型，各形態，各用途:全球機會分析、產業預測，2021-2031年

Nutraceutical Ingredients Market By Type, By Form, By Application : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日期: | 出版商: Allied Market Research | 英文 300 Pages | 商品交期: 2-3個工作天內

價格

營養補充品成分的全球市場2021年達到1639億美元，2031年預計達3273億美元，從2022年到2031年以7.3％的年複合成長率成長。

營養補充品成分的食品，飲料，營養補充品，個人保健產品，動物飼料的配合，應用於新生兒、孕婦營養，運動營養，醫療營養，動物營養。感染疾病和慢性疾病增加，在食品和飲料用途的營養補充品成分的使用擴大，成為推動營養補充品成分的全球市場擴大的主要原因。

目錄

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義和範圍
  • 主要調查結果
    • 主要的投資口袋
  • 波特的五力分析
  • 主要企業的定位
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • COVID-19 影響分析
  • 市場佔有率分析
  • 價值鏈分析

第4章 營養成分市場:各類型

  • 概要
    • 市場規模及預測
  • 益生菌
    • 主要的市場趨勢，成長要素，機會
    • 市場規模、預測:各地區
    • 市場分析:各國
  • 維他命
    • 主要的市場趨勢，成長要素，機會
    • 市場規模、預測:各地區
    • 市場分析:各國
  • 礦物
    • 主要的市場趨勢，成長要素，機會
    • 市場規模、預測:各地區
    • 市場分析:各國
  • 蛋白質
    • 主要的市場趨勢，成長要素，機會
    • 市場規模、預測:各地區
    • 市場分析:各國
    • 蛋白質保健品相關原料市場:各子類型
      • 植物性蛋白質的市場規模、預測:各地區
      • 動物性蛋白質的市場規模及預測:各地區
  • 食物纖維
    • 主要的市場趨勢，成長要素，機會
    • 市場規模及預測:各地區
    • 市場分析:各國
  • 其他
    • 主要的市場趨勢，成長要素，機會
    • 市場規模、預測:各地區
    • 市場分析:各國

第5章 營養補充品市場:各形態

  • 概要
    • 市場規模及預測
  • 乾燥
    • 主要的市場趨勢，成長要素，機會
    • 市場規模及預測:各地區
    • 市場分析:各國
  • 液體
    • 主要的市場趨勢，成長要素，機會
    • 市場規模、預測:各地區
    • 市場分析:各國

第6章 營養成分市場:各用途

  • 概要
    • 市場規模及預測
  • 營養補充品
    • 主要的市場趨勢，成長要素，機會
    • 市場規模、預測:各地區
    • 市場分析:各國
  • 機能性食品、食品和飲料
    • 主要的市場趨勢，成長要素，機會
    • 市場規模、預測:各地區
    • 市場分析:各國
  • 動物營養
    • 主要的市場趨勢，成長要素，機會
    • 市場規模、預測:各地區
    • 市場分析:各國
  • 其他
    • 主要的市場趨勢，成長要素，機會
    • 市場規模、預測:各地區
    • 市場分析:各國

第7章 營養成分市場:各地區

  • 概要
    • 市場規模及預測
  • 北美
    • 主要趨勢和機會
    • 北美市場規模、預測:各類型
      • 北美的蛋白質保健品相關原料市場:各子類型
    • 北美的市場規模、預測:各形態
    • 北美市場規模、預測:各用途
    • 北美市場規模、預測:各國
      • 美國
      • 加拿大
      • 墨西哥
  • 歐洲
    • 主要趨勢和機會
    • 歐洲的市場規模、預測:各類型
      • 歐洲的蛋白質保健品相關原料的市場:各子類型
    • 歐洲的市場規模、預測:各形態
    • 歐洲市場規模、預測:各用途
    • 歐洲市場規模、預測:各國
      • 英國
      • 芬蘭
      • 西班牙
      • 德國
      • 法國
      • 義大利
      • 其他的歐洲
  • 亞太地區
    • 主要趨勢和機會
    • 亞太地區的市場規模、預測:各類型
      • 亞太地區的蛋白質保健品相關原料市場:各子類型
    • 亞太地區的市場規模、預測:各形態
    • 亞太地區的市場規模、預測:各用途
    • 亞太地區的市場規模、預測:各國
      • 中國
      • 日本
      • 印度
      • 韓國
      • 澳洲
      • 紐西蘭
      • 其他亞太地區
  • LAMEA
    • 主要趨勢和機會
    • LAMEA的市場規模、預測:各類型
      • LAMEA的蛋白質保健品相關原料市場:各子類型
    • LAMEA的市場規模、預測:各形態
    • LAMEA的市場規模、預測:各用途
    • LAMEA的市場規模、預測:各國
      • 巴西
      • 南非
      • 沙烏地阿拉伯
      • LAMEA的其餘地區

第8章 企業形勢

  • 簡介
  • 主要成功策略
  • 主要十大公司的產品製圖
  • 競爭儀表板
  • 競爭的熱圖
  • 主要的發展

第9章 企業簡介

  • AMWAY CORPORATION
  • aor international
  • Archer Daniels Midland Company
  • Cargill, Incorporated
  • Danone
  • EID Parry India Ltd
  • General Mills, Inc.
  • Herbalife Ltd.
  • Innophos Holdings Inc
  • Matsun Nutrition
  • Mead Johnson
  • Nestle S.A.
  • natrol, inc.
  • Royal DSM
  • valensa international
Product Code: A00277

The global nutraceutical ingredients market was valued at $163.9 billion in 2021, and is projected to reach $327.3 billion by 2031, growing at a CAGR of 7.3% from 2022 to 2031.The incorporation of the nutraceutical ingredients into food, beverages, dietary supplements, personal care products, and animal feed has applications in newborn and maternal nutrition, sports nutrition, medical nutrition, and animal nutrition. The rise in the prevalence of infectious and chronic diseases, as well as the expanding usage of nutraceutical ingredients in food and beverage applications, are the main factors propelling the expansion of the global market for nutraceutical ingredients.

The nutraceutical ingredients market is analyzed based on type, form, application, and region. By type, the market is divided into probiotics, vitamins, minerals, proteins, dietary fibers, and others. Further, proteins segment is bifurcated into plant proteins and animal proteins. By form, the market is divided into dry and liquid. By application, it is classified into dietary supplements, functional food & beverage, animal nutrition, others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (the UK, Finland, Spain, Germany, France, Italy, and the rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, New Zealand, and the rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and Rest of LAMEA).

The demand for nutritional supplements and functional foods has increased as a result of the COVID-19 pandemic. The popularity of immunity-boosting supplements has significantly altered consumer behavior and purchasing habits. Additionally, following the COVID-19 pandemic, people's daily life will likely include preventive healthcare practices like taking dietary supplements. As a result, the global COVID-19 pandemic has made it possible for nutraceutical ingredients to establish a significant market presence.

The primary driver of the global market for nutraceutical ingredients is the increasing availability of vitamin-based supplements in departmental and other retail outlets. Due to their significant advantages, such as illness prevention, youthful vitality, and good health, these products are widely accepted by consumers. People of all ages take dietary supplements to consume the recommended dietary requirements. The diverse forms of these supplements include pills, tablets, powders, capsules, gel caps, and liquids.

The key players operating in the nutraceutical ingredients market have adopted product launch, business expansion, and merger & acquisition as its key strategies to expand their market share, increase profitability, and remain competitive in the market. The major players operating in the global nutraceutical ingredients market are Amway Corporation, AOR Inc., Archer Daniels Midland, Cargill Incorporated, Danone, EID Parry, General Mills, Herbalife International of America Inc., Innophos, Matsun Nutrition, Mead Johnson, Nestle SA, Natrol, Royal DSM, and Valensa International.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the nutraceutical ingredients market analysis from 2021 to 2031 to identify the prevailing nutraceutical ingredients market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the nutraceutical ingredients market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global nutraceutical ingredients market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Application

  • Dietary supplements
  • Functional food and beverage
  • Animal nutrition
  • Others

By Type

  • Probiotics
  • Vitamins
  • Minerals
  • Proteins
    • Sub-Type
    • Plant proteins
    • Animal proteins
  • Dietary fibers
  • Others

By Form

  • Dry
  • Liquid

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Finland
    • Spain
    • Germany
    • France
    • Italy
    • Rest Of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • New Zealand
    • Rest Of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa,
    • Saudi Arabia
    • Rest Of LAMEA
  • Key Market Players
    • AMWAY CORPORATION
    • aor international
    • Archer Daniels Midland Company
    • Cargill, Incorporated
    • Danone
    • EID Parry India Ltd
    • General Mills, Inc.
    • Herbalife Ltd.
    • Innophos Holdings Inc
    • Matsun Nutrition
    • Mead Johnson
    • , Nestle S.A.
    • natrol, inc.
    • Royal DSM
    • valensa international

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market
  • 3.7.Market Share Analysis
  • 3.8.Value Chain Analysis

CHAPTER 4: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Probiotics
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Vitamins
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Minerals
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country
  • 4.5 Proteins
    • 4.5.1 Key market trends, growth factors and opportunities
    • 4.5.2 Market size and forecast, by region
    • 4.5.3 Market analysis by country
    • 4.5.4 Proteins Nutraceutical Ingredients Market by Sub-Type
      • 4.5.4.1 Plant proteins Market size and forecast, by region
      • 4.5.4.2 Animal proteins Market size and forecast, by region
  • 4.6 Dietary fibers
    • 4.6.1 Key market trends, growth factors and opportunities
    • 4.6.2 Market size and forecast, by region
    • 4.6.3 Market analysis by country
  • 4.7 Others
    • 4.7.1 Key market trends, growth factors and opportunities
    • 4.7.2 Market size and forecast, by region
    • 4.7.3 Market analysis by country

CHAPTER 5: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Dry
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Liquid
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country

CHAPTER 6: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Dietary supplements
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Functional food and beverage
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country
  • 6.4 Animal nutrition
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market analysis by country
  • 6.5 Others
    • 6.5.1 Key market trends, growth factors and opportunities
    • 6.5.2 Market size and forecast, by region
    • 6.5.3 Market analysis by country

CHAPTER 7: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Type
      • 7.2.2.1 North America Proteins Nutraceutical Ingredients Market by Sub-Type
    • 7.2.3 North America Market size and forecast, by Form
    • 7.2.4 North America Market size and forecast, by Application
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Type
      • 7.2.5.1.2 Market size and forecast, by Form
      • 7.2.5.1.3 Market size and forecast, by Application
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Type
      • 7.2.5.2.2 Market size and forecast, by Form
      • 7.2.5.2.3 Market size and forecast, by Application
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Type
      • 7.2.5.3.2 Market size and forecast, by Form
      • 7.2.5.3.3 Market size and forecast, by Application
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Type
      • 7.3.2.1 Europe Proteins Nutraceutical Ingredients Market by Sub-Type
    • 7.3.3 Europe Market size and forecast, by Form
    • 7.3.4 Europe Market size and forecast, by Application
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 UK
      • 7.3.5.1.1 Market size and forecast, by Type
      • 7.3.5.1.2 Market size and forecast, by Form
      • 7.3.5.1.3 Market size and forecast, by Application
      • 7.3.5.2 Finland
      • 7.3.5.2.1 Market size and forecast, by Type
      • 7.3.5.2.2 Market size and forecast, by Form
      • 7.3.5.2.3 Market size and forecast, by Application
      • 7.3.5.3 Spain
      • 7.3.5.3.1 Market size and forecast, by Type
      • 7.3.5.3.2 Market size and forecast, by Form
      • 7.3.5.3.3 Market size and forecast, by Application
      • 7.3.5.4 Germany
      • 7.3.5.4.1 Market size and forecast, by Type
      • 7.3.5.4.2 Market size and forecast, by Form
      • 7.3.5.4.3 Market size and forecast, by Application
      • 7.3.5.5 France
      • 7.3.5.5.1 Market size and forecast, by Type
      • 7.3.5.5.2 Market size and forecast, by Form
      • 7.3.5.5.3 Market size and forecast, by Application
      • 7.3.5.6 Italy
      • 7.3.5.6.1 Market size and forecast, by Type
      • 7.3.5.6.2 Market size and forecast, by Form
      • 7.3.5.6.3 Market size and forecast, by Application
      • 7.3.5.7 Rest of Europe
      • 7.3.5.7.1 Market size and forecast, by Type
      • 7.3.5.7.2 Market size and forecast, by Form
      • 7.3.5.7.3 Market size and forecast, by Application
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Type
      • 7.4.2.1 Asia-Pacific Proteins Nutraceutical Ingredients Market by Sub-Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Form
    • 7.4.4 Asia-Pacific Market size and forecast, by Application
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 China
      • 7.4.5.1.1 Market size and forecast, by Type
      • 7.4.5.1.2 Market size and forecast, by Form
      • 7.4.5.1.3 Market size and forecast, by Application
      • 7.4.5.2 Japan
      • 7.4.5.2.1 Market size and forecast, by Type
      • 7.4.5.2.2 Market size and forecast, by Form
      • 7.4.5.2.3 Market size and forecast, by Application
      • 7.4.5.3 India
      • 7.4.5.3.1 Market size and forecast, by Type
      • 7.4.5.3.2 Market size and forecast, by Form
      • 7.4.5.3.3 Market size and forecast, by Application
      • 7.4.5.4 South Korea
      • 7.4.5.4.1 Market size and forecast, by Type
      • 7.4.5.4.2 Market size and forecast, by Form
      • 7.4.5.4.3 Market size and forecast, by Application
      • 7.4.5.5 Australia
      • 7.4.5.5.1 Market size and forecast, by Type
      • 7.4.5.5.2 Market size and forecast, by Form
      • 7.4.5.5.3 Market size and forecast, by Application
      • 7.4.5.6 New Zealand
      • 7.4.5.6.1 Market size and forecast, by Type
      • 7.4.5.6.2 Market size and forecast, by Form
      • 7.4.5.6.3 Market size and forecast, by Application
      • 7.4.5.7 Rest of Asia-Pacific
      • 7.4.5.7.1 Market size and forecast, by Type
      • 7.4.5.7.2 Market size and forecast, by Form
      • 7.4.5.7.3 Market size and forecast, by Application
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Type
      • 7.5.2.1 LAMEA Proteins Nutraceutical Ingredients Market by Sub-Type
    • 7.5.3 LAMEA Market size and forecast, by Form
    • 7.5.4 LAMEA Market size and forecast, by Application
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Market size and forecast, by Type
      • 7.5.5.1.2 Market size and forecast, by Form
      • 7.5.5.1.3 Market size and forecast, by Application
      • 7.5.5.2 South Africa,
      • 7.5.5.2.1 Market size and forecast, by Type
      • 7.5.5.2.2 Market size and forecast, by Form
      • 7.5.5.2.3 Market size and forecast, by Application
      • 7.5.5.3 Saudi Arabia
      • 7.5.5.3.1 Market size and forecast, by Type
      • 7.5.5.3.2 Market size and forecast, by Form
      • 7.5.5.3.3 Market size and forecast, by Application
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Market size and forecast, by Type
      • 7.5.5.4.2 Market size and forecast, by Form
      • 7.5.5.4.3 Market size and forecast, by Application

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 AMWAY CORPORATION
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 aor international
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Archer Daniels Midland Company
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 Cargill, Incorporated
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Danone
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 EID Parry India Ltd
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 General Mills, Inc.
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Herbalife Ltd.
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Innophos Holdings Inc
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Matsun Nutrition
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments
  • 9.11 Mead Johnson
    • 9.11.1 Company overview
    • 9.11.2 Company snapshot
    • 9.11.3 Operating business segments
    • 9.11.4 Product portfolio
    • 9.11.5 Business performance
    • 9.11.6 Key strategic moves and developments
  • 9.12 , Nestle S.A.
    • 9.12.1 Company overview
    • 9.12.2 Company snapshot
    • 9.12.3 Operating business segments
    • 9.12.4 Product portfolio
    • 9.12.5 Business performance
    • 9.12.6 Key strategic moves and developments
  • 9.13 natrol, inc.
    • 9.13.1 Company overview
    • 9.13.2 Company snapshot
    • 9.13.3 Operating business segments
    • 9.13.4 Product portfolio
    • 9.13.5 Business performance
    • 9.13.6 Key strategic moves and developments
  • 9.14 Royal DSM
    • 9.14.1 Company overview
    • 9.14.2 Company snapshot
    • 9.14.3 Operating business segments
    • 9.14.4 Product portfolio
    • 9.14.5 Business performance
    • 9.14.6 Key strategic moves and developments
  • 9.15 valensa international
    • 9.15.1 Company overview
    • 9.15.2 Company snapshot
    • 9.15.3 Operating business segments
    • 9.15.4 Product portfolio
    • 9.15.5 Business performance
    • 9.15.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 2. NUTRACEUTICAL INGREDIENTS MARKET, FOR PROBIOTICS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. NUTRACEUTICAL INGREDIENTS MARKET FOR PROBIOTICS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. NUTRACEUTICAL INGREDIENTS MARKET, FOR VITAMINS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 5. NUTRACEUTICAL INGREDIENTS MARKET FOR VITAMINS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 6. NUTRACEUTICAL INGREDIENTS MARKET, FOR MINERALS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 7. NUTRACEUTICAL INGREDIENTS MARKET FOR MINERALS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 8. NUTRACEUTICAL INGREDIENTS MARKET, FOR PROTEINS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 9. NUTRACEUTICAL INGREDIENTS MARKET FOR PROTEINS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 10. GLOBAL PROTEINS NUTRACEUTICAL INGREDIENTS MARKET, BY SUB-TYPE, 2021-2031 ($MILLION)
  • TABLE 11. NUTRACEUTICAL INGREDIENTS MARKET, FOR PLANT PROTEINS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 12. NUTRACEUTICAL INGREDIENTS MARKET, FOR ANIMAL PROTEINS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 13. NUTRACEUTICAL INGREDIENTS MARKET, FOR DIETARY FIBERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 14. NUTRACEUTICAL INGREDIENTS MARKET FOR DIETARY FIBERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 15. NUTRACEUTICAL INGREDIENTS MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 16. NUTRACEUTICAL INGREDIENTS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 17. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 18. NUTRACEUTICAL INGREDIENTS MARKET, FOR DRY, BY REGION, 2021-2031 ($MILLION)
  • TABLE 19. NUTRACEUTICAL INGREDIENTS MARKET FOR DRY, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 20. NUTRACEUTICAL INGREDIENTS MARKET, FOR LIQUID, BY REGION, 2021-2031 ($MILLION)
  • TABLE 21. NUTRACEUTICAL INGREDIENTS MARKET FOR LIQUID, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 22. GLOBAL NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 23. NUTRACEUTICAL INGREDIENTS MARKET, FOR DIETARY SUPPLEMENTS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 24. NUTRACEUTICAL INGREDIENTS MARKET FOR DIETARY SUPPLEMENTS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 25. NUTRACEUTICAL INGREDIENTS MARKET, FOR FUNCTIONAL FOOD AND BEVERAGE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 26. NUTRACEUTICAL INGREDIENTS MARKET FOR FUNCTIONAL FOOD AND BEVERAGE, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 27. NUTRACEUTICAL INGREDIENTS MARKET, FOR ANIMAL NUTRITION, BY REGION, 2021-2031 ($MILLION)
  • TABLE 28. NUTRACEUTICAL INGREDIENTS MARKET FOR ANIMAL NUTRITION, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 29. NUTRACEUTICAL INGREDIENTS MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 30. NUTRACEUTICAL INGREDIENTS MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 31. NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 32. NORTH AMERICA NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 33. NORTH AMERICA PROTEINS NUTRACEUTICAL INGREDIENTS MARKET, BY SUB-TYPE, 2021-2031 ($MILLION)
  • TABLE 34. NORTH AMERICA NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 35. NORTH AMERICA NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 36. NORTH AMERICA NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 37. U.S. NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 38. U.S. NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 39. U.S. NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 40. CANADA NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 41. CANADA NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 42. CANADA NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 43. MEXICO NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 44. MEXICO NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 45. MEXICO NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 46. EUROPE NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 47. EUROPE PROTEINS NUTRACEUTICAL INGREDIENTS MARKET, BY SUB-TYPE, 2021-2031 ($MILLION)
  • TABLE 48. EUROPE NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 49. EUROPE NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 50. EUROPE NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 51. UK NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 52. UK NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 53. UK NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 54. FINLAND NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 55. FINLAND NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 56. FINLAND NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 57. SPAIN NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 58. SPAIN NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 59. SPAIN NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 60. GERMANY NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 61. GERMANY NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 62. GERMANY NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 63. FRANCE NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 64. FRANCE NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 65. FRANCE NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 66. ITALY NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 67. ITALY NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 68. ITALY NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 69. REST OF EUROPE NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 70. REST OF EUROPE NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 71. REST OF EUROPE NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 72. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 73. ASIA-PACIFIC PROTEINS NUTRACEUTICAL INGREDIENTS MARKET, BY SUB-TYPE, 2021-2031 ($MILLION)
  • TABLE 74. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 75. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 76. ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 77. CHINA NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 78. CHINA NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 79. CHINA NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 80. JAPAN NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 81. JAPAN NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 82. JAPAN NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 83. INDIA NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 84. INDIA NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 85. INDIA NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 86. SOUTH KOREA NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 87. SOUTH KOREA NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 88. SOUTH KOREA NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 89. AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 90. AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 91. AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 92. NEW ZEALAND NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 93. NEW ZEALAND NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 94. NEW ZEALAND NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 95. REST OF ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 96. REST OF ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 97. REST OF ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 98. LAMEA NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 99. LAMEA PROTEINS NUTRACEUTICAL INGREDIENTS MARKET, BY SUB-TYPE, 2021-2031 ($MILLION)
  • TABLE 100. LAMEA NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 101. LAMEA NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 102. LAMEA NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 103. BRAZIL NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 104. BRAZIL NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 105. BRAZIL NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 106. SOUTH AFRICA, NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 107. SOUTH AFRICA, NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 108. SOUTH AFRICA, NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 109. SAUDI ARABIA NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 110. SAUDI ARABIA NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 111. SAUDI ARABIA NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 112. REST OF LAMEA NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 113. REST OF LAMEA NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2021-2031 ($MILLION)
  • TABLE 114. REST OF LAMEA NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
  • TABLE 115.AMWAY CORPORATION: COMPANY SNAPSHOT
  • TABLE 116.AMWAY CORPORATION: OPERATING SEGMENTS
  • TABLE 117.AMWAY CORPORATION: PRODUCT PORTFOLIO
  • TABLE 118.AMWAY CORPORATION: NET SALES,
  • TABLE 119.AMWAY CORPORATION: KEY STRATERGIES
  • TABLE 120.AOR INTERNATIONAL: COMPANY SNAPSHOT
  • TABLE 121.AOR INTERNATIONAL: OPERATING SEGMENTS
  • TABLE 122.AOR INTERNATIONAL: PRODUCT PORTFOLIO
  • TABLE 123.AOR INTERNATIONAL: NET SALES,
  • TABLE 124.AOR INTERNATIONAL: KEY STRATERGIES
  • TABLE 125.ARCHER DANIELS MIDLAND COMPANY: COMPANY SNAPSHOT
  • TABLE 126.ARCHER DANIELS MIDLAND COMPANY: OPERATING SEGMENTS
  • TABLE 127.ARCHER DANIELS MIDLAND COMPANY: PRODUCT PORTFOLIO
  • TABLE 128.ARCHER DANIELS MIDLAND COMPANY: NET SALES,
  • TABLE 129.ARCHER DANIELS MIDLAND COMPANY: KEY STRATERGIES
  • TABLE 130.CARGILL, INCORPORATED: COMPANY SNAPSHOT
  • TABLE 131.CARGILL, INCORPORATED: OPERATING SEGMENTS
  • TABLE 132.CARGILL, INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 133.CARGILL, INCORPORATED: NET SALES,
  • TABLE 134.CARGILL, INCORPORATED: KEY STRATERGIES
  • TABLE 135.DANONE: COMPANY SNAPSHOT
  • TABLE 136.DANONE: OPERATING SEGMENTS
  • TABLE 137.DANONE: PRODUCT PORTFOLIO
  • TABLE 138.DANONE: NET SALES,
  • TABLE 139.DANONE: KEY STRATERGIES
  • TABLE 140.EID PARRY INDIA LTD: COMPANY SNAPSHOT
  • TABLE 141.EID PARRY INDIA LTD: OPERATING SEGMENTS
  • TABLE 142.EID PARRY INDIA LTD: PRODUCT PORTFOLIO
  • TABLE 143.EID PARRY INDIA LTD: NET SALES,
  • TABLE 144.EID PARRY INDIA LTD: KEY STRATERGIES
  • TABLE 145.GENERAL MILLS, INC.: COMPANY SNAPSHOT
  • TABLE 146.GENERAL MILLS, INC.: OPERATING SEGMENTS
  • TABLE 147.GENERAL MILLS, INC.: PRODUCT PORTFOLIO
  • TABLE 148.GENERAL MILLS, INC.: NET SALES,
  • TABLE 149.GENERAL MILLS, INC.: KEY STRATERGIES
  • TABLE 150.HERBALIFE LTD.: COMPANY SNAPSHOT
  • TABLE 151.HERBALIFE LTD.: OPERATING SEGMENTS
  • TABLE 152.HERBALIFE LTD.: PRODUCT PORTFOLIO
  • TABLE 153.HERBALIFE LTD.: NET SALES,
  • TABLE 154.HERBALIFE LTD.: KEY STRATERGIES
  • TABLE 155.INNOPHOS HOLDINGS INC: COMPANY SNAPSHOT
  • TABLE 156.INNOPHOS HOLDINGS INC: OPERATING SEGMENTS
  • TABLE 157.INNOPHOS HOLDINGS INC: PRODUCT PORTFOLIO
  • TABLE 158.INNOPHOS HOLDINGS INC: NET SALES,
  • TABLE 159.INNOPHOS HOLDINGS INC: KEY STRATERGIES
  • TABLE 160.MATSUN NUTRITION: COMPANY SNAPSHOT
  • TABLE 161.MATSUN NUTRITION: OPERATING SEGMENTS
  • TABLE 162.MATSUN NUTRITION: PRODUCT PORTFOLIO
  • TABLE 163.MATSUN NUTRITION: NET SALES,
  • TABLE 164.MATSUN NUTRITION: KEY STRATERGIES
  • TABLE 165.MEAD JOHNSON: COMPANY SNAPSHOT
  • TABLE 166.MEAD JOHNSON: OPERATING SEGMENTS
  • TABLE 167.MEAD JOHNSON: PRODUCT PORTFOLIO
  • TABLE 168.MEAD JOHNSON: NET SALES,
  • TABLE 169.MEAD JOHNSON: KEY STRATERGIES
  • TABLE 170., NESTLE S.A.: COMPANY SNAPSHOT
  • TABLE 171., NESTLE S.A.: OPERATING SEGMENTS
  • TABLE 172., NESTLE S.A.: PRODUCT PORTFOLIO
  • TABLE 173., NESTLE S.A.: NET SALES,
  • TABLE 174., NESTLE S.A.: KEY STRATERGIES
  • TABLE 175.NATROL, INC.: COMPANY SNAPSHOT
  • TABLE 176.NATROL, INC.: OPERATING SEGMENTS
  • TABLE 177.NATROL, INC.: PRODUCT PORTFOLIO
  • TABLE 178.NATROL, INC.: NET SALES,
  • TABLE 179.NATROL, INC.: KEY STRATERGIES
  • TABLE 180.ROYAL DSM: COMPANY SNAPSHOT
  • TABLE 181.ROYAL DSM: OPERATING SEGMENTS
  • TABLE 182.ROYAL DSM: PRODUCT PORTFOLIO
  • TABLE 183.ROYAL DSM: NET SALES,
  • TABLE 184.ROYAL DSM: KEY STRATERGIES
  • TABLE 185.VALENSA INTERNATIONAL: COMPANY SNAPSHOT
  • TABLE 186.VALENSA INTERNATIONAL: OPERATING SEGMENTS
  • TABLE 187.VALENSA INTERNATIONAL: PRODUCT PORTFOLIO
  • TABLE 188.VALENSA INTERNATIONAL: NET SALES,
  • TABLE 189.VALENSA INTERNATIONAL: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.NUTRACEUTICAL INGREDIENTS MARKET SEGMENTATION
  • FIGURE 2.NUTRACEUTICAL INGREDIENTS MARKET,2021-2031
  • FIGURE 3.NUTRACEUTICAL INGREDIENTS MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.NUTRACEUTICAL INGREDIENTS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.MARKET SHARE ANALYSIS
  • FIGURE 13.VALUE CHAIN ANALYSIS
  • FIGURE 14.NUTRACEUTICAL INGREDIENTS MARKET,BY TYPE,2021(%)
  • FIGURE 15.COMPARATIVE SHARE ANALYSIS OF PROBIOTICS NUTRACEUTICAL INGREDIENTS MARKET,2021-2031(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF VITAMINS NUTRACEUTICAL INGREDIENTS MARKET,2021-2031(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF MINERALS NUTRACEUTICAL INGREDIENTS MARKET,2021-2031(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF PROTEINS NUTRACEUTICAL INGREDIENTS MARKET,2021-2031(%)
  • FIGURE 19.COMPARATIVE SHARE ANALYSIS OF DIETARY FIBERS NUTRACEUTICAL INGREDIENTS MARKET,2021-2031(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF OTHERS NUTRACEUTICAL INGREDIENTS MARKET,2021-2031(%)
  • FIGURE 21.NUTRACEUTICAL INGREDIENTS MARKET,BY FORM,2021(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF DRY NUTRACEUTICAL INGREDIENTS MARKET,2021-2031(%)
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF LIQUID NUTRACEUTICAL INGREDIENTS MARKET,2021-2031(%)
  • FIGURE 24.NUTRACEUTICAL INGREDIENTS MARKET,BY APPLICATION,2021(%)
  • FIGURE 25.COMPARATIVE SHARE ANALYSIS OF DIETARY SUPPLEMENTS NUTRACEUTICAL INGREDIENTS MARKET,2021-2031(%)
  • FIGURE 26.COMPARATIVE SHARE ANALYSIS OF FUNCTIONAL FOOD AND BEVERAGE NUTRACEUTICAL INGREDIENTS MARKET,2021-2031(%)
  • FIGURE 27.COMPARATIVE SHARE ANALYSIS OF ANIMAL NUTRITION NUTRACEUTICAL INGREDIENTS MARKET,2021-2031(%)
  • FIGURE 28.COMPARATIVE SHARE ANALYSIS OF OTHERS NUTRACEUTICAL INGREDIENTS MARKET,2021-2031(%)
  • FIGURE 29.NUTRACEUTICAL INGREDIENTS MARKET BY REGION,2021
  • FIGURE 30.U.S. NUTRACEUTICAL INGREDIENTS MARKET,2021-2031($MILLION)
  • FIGURE 31.CANADA NUTRACEUTICAL INGREDIENTS MARKET,2021-2031($MILLION)
  • FIGURE 32.MEXICO NUTRACEUTICAL INGREDIENTS MARKET,2021-2031($MILLION)
  • FIGURE 33.UK NUTRACEUTICAL INGREDIENTS MARKET,2021-2031($MILLION)
  • FIGURE 34.FINLAND NUTRACEUTICAL INGREDIENTS MARKET,2021-2031($MILLION)
  • FIGURE 35.SPAIN NUTRACEUTICAL INGREDIENTS MARKET,2021-2031($MILLION)
  • FIGURE 36.GERMANY NUTRACEUTICAL INGREDIENTS MARKET,2021-2031($MILLION)
  • FIGURE 37.FRANCE NUTRACEUTICAL INGREDIENTS MARKET,2021-2031($MILLION)
  • FIGURE 38.ITALY NUTRACEUTICAL INGREDIENTS MARKET,2021-2031($MILLION)
  • FIGURE 39.REST OF EUROPE NUTRACEUTICAL INGREDIENTS MARKET,2021-2031($MILLION)
  • FIGURE 40.CHINA NUTRACEUTICAL INGREDIENTS MARKET,2021-2031($MILLION)
  • FIGURE 41.JAPAN NUTRACEUTICAL INGREDIENTS MARKET,2021-2031($MILLION)
  • FIGURE 42.INDIA NUTRACEUTICAL INGREDIENTS MARKET,2021-2031($MILLION)
  • FIGURE 43.SOUTH KOREA NUTRACEUTICAL INGREDIENTS MARKET,2021-2031($MILLION)
  • FIGURE 44.AUSTRALIA NUTRACEUTICAL INGREDIENTS MARKET,2021-2031($MILLION)
  • FIGURE 45.NEW ZEALAND NUTRACEUTICAL INGREDIENTS MARKET,2021-2031($MILLION)
  • FIGURE 46.REST OF ASIA-PACIFIC NUTRACEUTICAL INGREDIENTS MARKET,2021-2031($MILLION)
  • FIGURE 47.BRAZIL NUTRACEUTICAL INGREDIENTS MARKET,2021-2031($MILLION)
  • FIGURE 48.SOUTH AFRICA, NUTRACEUTICAL INGREDIENTS MARKET,2021-2031($MILLION)
  • FIGURE 49.SAUDI ARABIA NUTRACEUTICAL INGREDIENTS MARKET,2021-2031($MILLION)
  • FIGURE 50.REST OF LAMEA NUTRACEUTICAL INGREDIENTS MARKET,2021-2031($MILLION)
  • FIGURE 51. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 52. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 53. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 54.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 55.COMPETITIVE DASHBOARD
  • FIGURE 56.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 57.AMWAY CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 58.AOR INTERNATIONAL.: NET SALES ,($MILLION)
  • FIGURE 59.ARCHER DANIELS MIDLAND COMPANY.: NET SALES ,($MILLION)
  • FIGURE 60.CARGILL, INCORPORATED.: NET SALES ,($MILLION)
  • FIGURE 61.DANONE.: NET SALES ,($MILLION)
  • FIGURE 62.EID PARRY INDIA LTD.: NET SALES ,($MILLION)
  • FIGURE 63.GENERAL MILLS, INC..: NET SALES ,($MILLION)
  • FIGURE 64.HERBALIFE LTD..: NET SALES ,($MILLION)
  • FIGURE 65.INNOPHOS HOLDINGS INC.: NET SALES ,($MILLION)
  • FIGURE 66.MATSUN NUTRITION.: NET SALES ,($MILLION)
  • FIGURE 67.MEAD JOHNSON.: NET SALES ,($MILLION)
  • FIGURE 68., NESTLE S.A..: NET SALES ,($MILLION)
  • FIGURE 69.NATROL, INC..: NET SALES ,($MILLION)
  • FIGURE 70.ROYAL DSM.: NET SALES ,($MILLION)
  • FIGURE 71.VALENSA INTERNATIONAL.: NET SALES ,($MILLION)